Published in Minim Invasive Ther Allied Technol on January 01, 2006
Traversing the many paths of workflow research: developing a conceptual framework of workflow terminology through a systematic literature review. J Am Med Inform Assoc (2010) 1.46
Applying systems engineering principles in improving health care delivery. J Gen Intern Med (2007) 1.25
Reduction in new metastases in breast cancer with adjuvant clodronate treatment. N Engl J Med (1998) 6.09
Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol (2004) 2.34
Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies. Gynecol Oncol (2009) 1.69
The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells. Horm Metab Res (2003) 1.49
Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment. Breast (2009) 1.47
Effect of medroxyprogesterone acetate and norethisterone on serum-stimulated and estradiol-inhibited proliferation of human coronary artery smooth muscle cells. Menopause (2001) 1.43
Possible causal role of lisinopril in a case of Kaposi's sarcoma. Br J Dermatol (2002) 1.39
Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study. Int J Gynecol Cancer (2003) 1.38
Treatment of the twin-twin transfusion syndrome: initial experience using laser-induced interstitial thermotherapy. Fetal Diagn Ther (1997) 1.38
Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation. Br J Cancer (1998) 1.28
Is human chorionic gonadotropin directly involved in the regulation of human implantation? Mol Cell Endocrinol (2007) 1.27
Mega-introns in the dynein gene DhDhc7(Y) on the heterochromatic Y chromosome give rise to the giant threads loops in primary spermatocytes of Drosophila hydei. Genetics (2000) 1.23
Statins can inhibit proliferation of human breast cancer cells in vitro. Exp Clin Endocrinol Diabetes (2003) 1.17
Breast cancer patients' expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patients. Ann Oncol (2007) 1.16
Massive cavernous lymphangioma of the breast and thoracic wall: case report and literature review. Lymphology (2006) 1.11
Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients. Ann Oncol (2012) 1.11
Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. Int J Cancer (1998) 1.04
A MAGE-A1 HLA-A A*0201 epitope identified by mass spectrometry. Cancer Res (2001) 1.03
Complete extirpation of benign breast lesions with an ultrasound-guided vacuum biopsy system. Ultrasound Obstet Gynecol (2007) 1.01
Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients. Int J Cancer (2001) 0.99
The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse. Breast Cancer Res Treat (2013) 0.98
Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid. Mol Hum Reprod (2001) 0.94
A multicenter survey of complications associated with 21,676 operative hysteroscopies. Eur J Obstet Gynecol Reprod Biol (2002) 0.93
Changes of serum HER2 status during clinical course of metastatic breast cancer patients. Anticancer Res (2005) 0.92
COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy. Ann Oncol (2013) 0.92
Molecular detection of thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease by RT-PCR. Br J Cancer (2000) 0.91
Nuclear peroxisome proliferator-activated receptors alpha and gamma have opposing effects on monocyte chemotaxis in endometriosis. J Clin Endocrinol Metab (2001) 0.90
An endoscopically assisted technique for construction of a neovagina. Arch Gynecol Obstet (1992) 0.90
Skin-sparing mastectomy and immediate breast reconstruction: incidence of recurrence in patients with invasive breast cancer. Breast (2004) 0.90
A newly developed morcellator creates a new dimension in minimally invasive surgery. J Minim Invasive Gynecol (2007) 0.90
Sentinel node identification and intraoperative lymphatic mapping. First results of a pilot study in patients with endometrial cancer. Eur J Gynaecol Oncol (2004) 0.89
Class-specific pro-apoptotic effect of statins on human vascular endothelial cells. Z Kardiol (2004) 0.89
Nodal status--its impact on prognosis in advanced ovarian cancer. J Cancer Res Clin Oncol (2011) 0.88
Does 3-D sonography bring any advantage to noninvasive breast diagnostics? Ultrasound Med Biol (2004) 0.88
Inhibitory effect of statins on the proliferation of human breast cancer cells. Int J Clin Pharmacol Ther (2004) 0.88
[Sonographic criteria for the differentiation of benign and malignant breast lesions using real-time spatial compound imaging in combination with XRES adaptive image processing]. Ultraschall Med (2010) 0.88
Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine. Ann Oncol (2007) 0.87
Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study. Eur J Cancer (2004) 0.86
The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer. J Cancer Res Clin Oncol (2002) 0.86
Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells. Climacteric (2009) 0.86
Detection of thyroid peroxidase mRNA in peripheral blood of patients with malignant and benign thyroid diseases. J Mol Endocrinol (2002) 0.86
Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer. Br J Cancer (2008) 0.86
Detection of disseminated tumor cells in patients with gynecological cancers. Gynecol Oncol (2006) 0.86
Down-regulation of CD28, TCR-zeta (zeta) and up-regulation of FAS in peripheral cytotoxic T-cells of primary breast cancer patients. Anticancer Res (2008) 0.85
Tibolone versus 17beta-estradiol/norethisterone: effects on the proliferation of human breast cancer cells. Eur J Gynaecol Oncol (2002) 0.85
Association of vascular endothelial growth factor expression with tumor cell proliferation in ovarian carcinoma. Anticancer Res (1997) 0.85
Effect of tamoxifen and 2-methoxyestradiol alone and in combination on human breast cancer cell proliferation. J Steroid Biochem Mol Biol (2003) 0.85
Breast cancer metastatic to the uterine cervix: analysis of a rare event. Cancer Invest (1999) 0.85
Effects of tibolone on human breast cancer cells and human vascular coronary cells. Arch Gynecol Obstet (2003) 0.84
Her-2/neu expression in breast cancer--A comparison of different diagnostic methods. Anticancer Res (2005) 0.84
Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen. Horm Metab Res (2004) 0.84
Ultrasound guided cryoablation of fibroadenomas. Ultraschall Med (2012) 0.84
Further evidence for direct vascular actions of statins: effect on endothelial nitric oxide synthase and adhesion molecules. Exp Clin Endocrinol Diabetes (2001) 0.83
Different effects of estradiol and various antiestrogens on TNF-alpha-induced changes of biochemical markers for growth and invasion of human breast cancer cells. Life Sci (2005) 0.83
Identification and characterization of neutral endopeptidase (EC 3. 4. 24. 11) from human prostasomes--localization in prostatic tissue and cell lines. Prostate (2001) 0.83
Alternative splicing and cycling kinetics of myosin change during hypertrophy of human smooth muscle cells. J Cell Biochem (1997) 0.83
The laser diffractoscope - a new and fast system to analyse red blood cell flexibility with high accuracy. Lasers Med Sci (2003) 0.83
Prenatal diagnosis and perinatal management of left coronary artery to right atrium fistula. Ultrasound Obstet Gynecol (2002) 0.82
Effect of deviation from the mid-sagittal plane on the measurement of fetal nuchal translucency. Ultrasound Obstet Gynecol (2010) 0.82
Genetic determinants of insulin action in polycystic ovary syndrome. Exp Clin Endocrinol Diabetes (2005) 0.82
Estradiol metabolites are potent mitogenic substances for human ovarian cancer cells. Eur J Gynaecol Oncol (2005) 0.82
Regulated on activation, normal T-cell-expressed and -secreted mRNA expression in normal endometrium and endometriotic implants: assessment of autocrine/paracrine regulation by in situ hybridization. Am J Pathol (2001) 0.82
Selective microdochectomy after ductoscopic wire marking in women with pathological nipple discharge. BMC Cancer (2009) 0.82
Interdisciplinary consensus recommendations for the use of vacuum-assisted breast biopsy under sonographic guidance: first update 2012. Ultraschall Med (2012) 0.81
Inhibition of proliferation and differentiation by RU 486 in human endometrial stromal and epithelial cells in vitro. Exp Clin Endocrinol Diabetes (2000) 0.81
Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer. Br J Cancer (1997) 0.81
Management of late recurrence of a low-grade endometrial stromal sarcoma (LGESS): treatment with letrozole. Anticancer Res (2007) 0.81
Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase. Gynecol Oncol (2013) 0.80
Relevance and methods of interventional breast sonography in preoperative axillary lymph node staging. Ultraschall Med (2011) 0.80
Sentinel lymph node mapping in endometrial cancer: a concept ready for clinical routine? Arch Gynecol Obstet (2014) 0.80
Evaluation and validation of a new risk score (CLEOPATRA score) to predict the probability of premature delivery for patients with threatened preterm labor. Ultrasound Obstet Gynecol (2005) 0.80
Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3. Clin Cancer Res (1999) 0.80
Localization in tissues and secretion of eotaxin by cells from normal endometrium and endometriosis. J Clin Endocrinol Metab (2000) 0.80
[Significance of myoma-induced complications in pregnancy. A comparative analysis of pregnancy course with and without myoma involvement]. Z Geburtshilfe Neonatol (1998) 0.80
Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer. Semin Oncol (1998) 0.80
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial. Eur J Cancer (2004) 0.80
Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancer. Breast Cancer Res Treat (1998) 0.80
Multifibre Application in Laser-Induced Interstitial Thermotherapy under On-Line MR Control. Lasers Med Sci (2000) 0.79
3D interstitial HDR brachytherapy combined with 3D external beam radiotherapy and androgen deprivation for prostate cancer. Preliminary results. Strahlenther Onkol (2000) 0.79
[Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: implications for the radiation oncologist]. Strahlenther Onkol (2012) 0.79
Effect of magnesium on red blood cell deformability in pregnancy. Hypertens Pregnancy (2005) 0.79
Valsartan and candesartan can inhibit deteriorating effects of angiotensin II on coronary endothelial function. J Renin Angiotensin Aldosterone Syst (2001) 0.79
Effect of an estrogen/statin combination on biochemical markers of endothelial function in human coronary artery cell cultures. Menopause (2001) 0.79
Long-term effects on the intelligence of children treated for acute lymphoblastic leukemia. Cancer Invest (2001) 0.79
New interstitial HDR brachytherapy technique for prostate cancer: CT based 3D planning after transrectal implantation. Radiother Oncol (1999) 0.79